^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    DB-1310

    i
    Company:
    DualityBio
    Drug class:
    Topoisomerase I inhibitor, HER3-targeted antibody-drug conjugate
    Related drugs:
    Apply
    A Study of DB-1310 in Advanced/Metastatic Solid Tumors (DB-1310-O-1001) (NCT05785741)
    Phase 1/2
    DualityBio Inc.
    Recruiting
    Last update posted :
    02/23/2024
    Initiation :
    04/10/2023
    Primary completion :
    08/31/2026
    Completion :
    08/31/2026
    ERBB3
    |
    DB-1310